- Home
- NKSH vs CYBN Comparison
NKSH vs CYBN Comparison
Compare NKSH & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- CYBN
- Stock Information
- Founded
- NKSH 1891
- CYBN 2019
- Country
- NKSH United States
- CYBN Canada
- Employees
- NKSH N/A
- CYBN N/A
- Industry
- NKSH Major Banks
- CYBN Pharmaceuticals and Biotechnology
- Sector
- NKSH Finance
- CYBN Health Care
- Exchange
- NKSH Nasdaq
- CYBN Nasdaq
- Market Cap
- NKSH 172.6M
- CYBN 176.0M
- IPO Year
- NKSH N/A
- CYBN N/A
- Fundamental
- Price
- NKSH $28.58
- CYBN $7.10
- Analyst Decision
- NKSH Strong Buy
- CYBN Strong Buy
- Analyst Count
- NKSH 1
- CYBN 3
- Target Price
- NKSH $38.00
- CYBN $85.00
- AVG Volume (30 Days)
- NKSH 15.0K
- CYBN 370.5K
- Earning Date
- NKSH 08-13-2025
- CYBN 08-13-2025
- Dividend Yield
- NKSH 5.34%
- CYBN N/A
- EPS Growth
- NKSH 15.57
- CYBN N/A
- EPS
- NKSH 1.77
- CYBN N/A
- Revenue
- NKSH $49,801,000.00
- CYBN N/A
- Revenue This Year
- NKSH N/A
- CYBN N/A
- Revenue Next Year
- NKSH $5.93
- CYBN N/A
- P/E Ratio
- NKSH $15.96
- CYBN N/A
- Revenue Growth
- NKSH 16.22
- CYBN N/A
- 52 Week Low
- NKSH $23.75
- CYBN $4.81
- 52 Week High
- NKSH $32.89
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- NKSH 48.59
- CYBN 40.31
- Support Level
- NKSH $28.78
- CYBN $7.22
- Resistance Level
- NKSH $30.30
- CYBN $7.75
- Average True Range (ATR)
- NKSH 0.91
- CYBN 0.35
- MACD
- NKSH -0.03
- CYBN -0.04
- Stochastic Oscillator
- NKSH 38.84
- CYBN 5.44
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.